Janus Henderson Group PLC Sells 327,641 Shares of Danaher Corporation $DHR

Janus Henderson Group PLC trimmed its position in shares of Danaher Corporation (NYSE:DHR) by 4.8% during the first quarter, Holdings Channel.com reports. The firm owned 6,489,965 shares of the conglomerate’s stock after selling 327,641 shares during the period. Danaher accounts for 0.6% of Janus Henderson Group PLC’s holdings, making the stock its 27th biggest position. Janus Henderson Group PLC’s holdings in Danaher were worth $1,222,064,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of DHR. Main Street Group LTD bought a new stake in Danaher during the 1st quarter valued at $25,000. JPL Wealth Management LLC bought a new position in shares of Danaher in the third quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new position in shares of Danaher during the fourth quarter valued at about $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the fourth quarter worth about $27,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of NYSE DHR opened at $196.55 on Thursday. The company has a market capitalization of $138.17 billion, a PE ratio of 34.91, a PEG ratio of 2.48 and a beta of 0.79. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock’s 50 day moving average price is $187.44 and its 200-day moving average price is $195.95. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue was up 5.5% on a year-over-year basis. During the same period last year, the business posted $0.77 earnings per share. On average, equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio (DPR) is currently 28.42%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on DHR shares. UBS Group dropped their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Citigroup started coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. Evercore reaffirmed an “outperform” rating and set a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Finally, Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.